Coronavirus (COVID-19) news


Covid fears battle vaccine hopes, how is it moving markets?

Going into the post-pandemic era

Despite the serious problems with the availability of COVID-19 vaccines, the vast majority of people in the United States and Europe will have been vaccinated by the summer, so the public health situation will be largely the same in these parts of the world. However, despite the homogenization of these areas, it remains uncertain how long it will take people and businesses to return to pre-pandemic conditions.

How covid-19 impacts markets

The first case of Coronavirus (COVID-19) appeared in December 2019 in Wuhan, China. Since early 2020, this disease has spread rapidly, generating medical crises, overwhelming hospitals and prompting governments to enact lockdowns around the world.

During the first months, investors responded with a sharp panic-selling response to the possible economic collapse, typical to such black-swan events.

The pandemic had a wide-ranging and severe impact on financial markets, including stocks, bonds, and commodities. Governments and central banks moved to shore up the economies.

It also had a substantial influence on businesses around the world. The uncertainty related to lockdown durations and economic recovery left many businesses closed and hit households hard.

From November 2020, several companies came out with vaccines and reported impressive efficacy rates . The immunization process is has advanced rapidly in Israel, the UK and the US, but lags elsewhere. Economic figures show that the vaccine and stimulus-led economic recovery is on track, but uncertainties remain considerable.

Latest coronavirus news

Latest coronavirus analysis


Coronavirus in United States

US’ Fauci: US may not need AstraZeneca COVID-19 vaccine

Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases (NIAID), told Reuters on Thursday that the United States may not need AstraZeneca's COVID-19 vaccine, even if it wins U.S. regulatory approval. “The vaccine, once hailed as another milestone in the fight against the COVID-19 pandemic, has been dogged by questions since late last year, even as it has been authorized for use by dozens of countries, not including the US,” said the news.


Coronavirus in Europe



Coronavirus vaccine

Despite the serious problems with the availability of COVID-19 vaccines, the vast majority of people in the United States and Europe will have been vaccinated by the summer, so the public health situation will be largely the same in these parts of the world. However, despite the homogenization of these areas, it remains uncertain how long it will take people and businesses to return to pre-pandemic conditions. Travel recovery, for example, will be slow. The European Union is likely to introduce quarantine-free cross-border crossings for those with vaccine passports, but restrictions on long-distance travel will remain in place for a long time to come.

Border controls between the vaccinated rich world and the unvaccinated poor world are likely to become stricter, especially if new mutations of the virus continue to appear.

Sponsor broker

Related content



Related content

Editors' Picks

AUD/USD: Bulls await Australian jobs data near three-week top above 0.7700

AUD/USD wavers in a choppy range above 0.7700 after rising the most in two months. Commodity-linked currencies benefited the most from the US dollar weakness, WTI gains. Powell repeated old tunes, Aussie employment figures expected to print mixed figures in March.

AUD/USD News

Gold stays depressed below $1,750 amid mixed sentiment

Gold holds lower grounds after the previous day’s downbeat performance. The yellow metal dropped for three days in the last four even as the DXY remains dismal around a one-month low. US dollar weakness tests the bears amid dull markets.

Gold News

BTC, ETH, and XRP stall at significant Fibonacci levels

A more stable trading experience will permit investors to hedge their bets on the future proliferation of cryptocurrencies with a well-placed company that will earn trading revenues that are not directly impacted by the price swings of any one token.

Read more

EUR/USD retains gains near the 1.2000 threshold

The EUR/USD pair advanced for a third consecutive day, holding near a daily high at 1.1986. Dollar bears leading the way higher ahead of US Retail Sales, employment data.

EUR/USD News

Coinbase (COIN) opens at $381 per share, 52.4% above reference valuation

Coinbase (COIN) Global Inc's stock opened at $381, 52.4% above the reference price of $250, in the highly-anticipated Nasdaq debut on Wednesday. 

Read more

US Latest Reports

US Latest News

Signatures